The Food and Drug Administration (FDA) has released a draft guideline titled “Evaluating Target Animal Safety and Effectiveness of Antibacterial New Animal Drugs for Bovine Mastitis,” now available for public comment. This guideline offers recommendations for medications that treat bovine mastitis through antibacterial agents administrable by intramammary infusion, but it might also be applicable to other forms or technologies. Individuals are encouraged to provide feedback until February 3, 2025. The document does not establish legal standards but reflects the current FDA views on the topic.
Simple Explanation
The FDA wants to hear what people think about a new set of advice for making safe and effective medicine for cows with a sickness called mastitis. This advice helps doctors pick the right medicine, but it's not like a strict rule, and everyone can share their thoughts about it until February 2025.